Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: Gurupup who wrote (1482)	3/19/1998 12:36:00 PM
From: David S.	Read Replies (1) \| Respond to of 5736

Lions and tigers and bears, oh my. ORG short was covered somewhere between 24-25. Fundamentally overvalued, massive short squeeze going on. I don't recall seeing in my contract where it says it is my responsibility to inform you of every trade done. Just wondering, if you do a deja news search on your friend Janybird, you'll see how much she liked Home Theatre Products, a company run by criminals which is now worth zero.

To: Gurupup who wrote (1482)	3/19/1998 8:28:00 PM
From: jpbrody	Read Replies (2) \| Respond to of 5736

Questions about Patents. Skipard, I didn't know you were holding 700,000+ shares in this one (that's over 5% of the outstanding shares). Do you work for the Mellon Bank group or Janssen-Meyers Associates? Or did you recently acquire your position? I only ask because I was paging through the SEC forms and the only investors with more than 5% of the company listed are Mellon, Janssen-Meyers, and the Macfarlanes. If you recently went over the 5% threshold, I guess you have 6 weeks to file, so it wouldn't be in the Edgar database yet. Also, I'd be interested in your opinions on two things: What kind of numbers do you project from a major deal? (I tried to take a guess in a previous post [See Message 3731940 ], but it made this stock look uninteresting to me. You obviously have much more experience and came to a different conclusion. I'd love to learn where we differ maybe I could learn something. So, specifically, what kind of royalty rate do you think CCSI can negotiate with a partner? What percentage of market share do you predict that CCSI will capture and by what dates? Second thing, how do you view their intellectual property position? I've examined one of their patents [See patents.ibm.com ] and I think it protects their particular algorithm for extracting bilirubin concentrations from skin color measurements, but it seems to me that it would be trivial to avoid a conflict with this and still make a non invasive bilirubin measuring device. (I would feel much, much better about this if CCSI had a patent like US Patent No. 4,029,085 "Method for determining bilirubin concentration from skin reflectance." [See patents.ibm.com ] but that's in the public domain now so anyone can practice it without a license. I would be interested in your opinions on these issues. -- Jim